This paper describes a simple, mild, and environmentally friendly approach to synthesize polystyrene/Ag (PS/Ag) nanocomposite spheres, which makes use of both reducing and stabilizing functions of polyvinylpyrrolidone (PVP) in aqueous media. In this approach, monodisperse polystyrene (PS) spheres, which are used as templates for the synthesis of core-shell nanocomposite spheres, are sulfonated first. Then, [Ag(NH(3))(2)](+) ions are adsorbed onto the surface of the PS template spheres via electrostatic attraction between -SO(3)H groups (grafted on the surface of the PS template spheres) and [Ag(NH(3))(2)](+) ions. [Ag(NH(3))(2)](+) ions are then reduced by and simultaneously protected by PVP. In this way, the PS/Ag nanocomposite spheres in aqueous media are obtained through a so-called one-pot method. Neither additional reducing agents nor toxic organic solvents are utilized during the synthesis process. Furthermore, the coverage degree and the particle size of Ag nanoparticles on PS/Ag nanocomposite spheres is easily tuned by changing the concentration of [Ag(NH(3))(2)](+) ions in aqueous media. Moreover, these PS/Ag nanocomposite spheres can be used as catalyst for the reduction of organic dyes and as antibacterial agents against Salmonella and Escherichia coli. In the present study, these PS/Ag nanocomposite spheres exhibit excellent catalytic properties (both in efficiency and recyclability) for the reduction of organic dyes, and the preliminary antibacterial assays indicate that these PS/Ag nanocomposite spheres also possess extraordinary antibacterial abilities against Salmonella and Escherichia coli.
Angiotensin II (Ang II) plays a pivotal role in cardiac fibrosis, and microRNAs (miRNAs) have been shown to participate in diverse pathological processes. Our aim is to identify the Ang II-induced miRNAs in cardiac fibroblasts (CFs). The miRNA array was used to analyze the miRNA expression profile in CFs treated by Ang II and control cells. Stem-loop real-time PCR was performed to re-measure the levels of the differentially expressed miRNAs. Analysis of miRNA arrays showed that 33 miRNAs were differentially expressed (13 up- and 20 downregulated) in response to Ang II (100 nM) for 24 h as compared to control cells. Quantitative PCR revealed that Ang II upregulated the levels of miR-132, -125b-3p and miR-146b but downregulated the levels of miR-300-5p, -204* and miR-181b in CFs. The trend of miRNA change is consistent with microarray and qRT-PCR. Bioinformatic analysis revealed that MMP9 as the target of miR-132, MMP16 as the target of miR-146b and TIMP3 as the target of miR-181b have been listed in the miR database with experimentally validated targets, indicating the potential role of those miRNAs in cardiac fibrosis. Our results demonstrated that we did identify a subset of miRNAs that was differentially expressed in Ang II-treated CFs, which provide a starting point to explore their potential roles in cardiac fibrosis and hypertension.
Cardiovascular and cerebrovascular ischemic disease is a large class of diseases that is harmful to human health. The primary treatment for the ischemic disease is to recover the blood perfusion and relieve the tissue hypoxia and the shortage of the nutrients in the supply of nutrients. In recent years, investigations found that IGF-1 has a protective effect on cardiovascular disease, especially in myocardial ischemia-reperfusion injury. Investigation into molecular mechanism of ischemia-reperfusion injury may offer potential targets for the development of novel diagnostic strategies. In this study we defined IGF-1 was differentially expressed in the I/R model of the Mus musculus and IGF-1 was the target gene of miR-29a and Let7f. After ischemia-reperfusion, the expression of miR-29a and Let7f increased, while the expression of IGF-1 decreased significantly in the animal model assay. Further studies have found that IGF-1 could inhibit cell apoptosis signaling pathway, thus protecting the reperfusion injury. These results provide new understanding of ischemia-reperfusion injury, with the hope of offering theoretical support for future therapeutic studies.
On-chip mode-division multiplexing (MDM) can increase the transmission capacity of a single optical bus waveguide. It is of great significance for the MDM systems to design the multimode waveguide bends (MWBs) with compact sizes. A method of designing the MWB using the inverse design algorithm is presented in this paper. Ultra-compact MWBs with high performances are realized by changing the curvature radius of the waveguide curve, and the fabrication process only requires a single step photo-lithography and plasma etching. The three-mode bent waveguide with an effective radius of only 9.35 µm is designed and tested. The theoretical excess losses of TE 0 , TE 1 , and TE 2 mode are less than 0.04 dB in a wide spectral range of 1500 to 1600 nm, and the crosstalks between all guided modes are all less than −29 dB. For the fabricated 90°waveguide bend the measured excess losses are 0.17, 0.04, and 0.16 dB at the central wavelength of 1550 nm, respectively, and the crosstalks between all three modes are less than −21 dB in the wavelength range from 1520 to 1600 nm. The proposed design method can be also extended to more mode-channels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.